Biography and Research Information
OverviewAI-generated summary
J. Benjamin Guise's research focuses on the pharmacological treatment of opioid use disorder and related conditions. His work investigates the efficacy of medications such as gabapentin, often in combination with other agents like buprenorphine and naltrexone, for managing withdrawal symptoms and supporting patient transition to long-term treatment.
Guise has published on randomized, placebo-controlled trials examining gabapentin's role during outpatient buprenorphine-assisted tapers and its impact on treatment outcomes, particularly in the context of fentanyl exposure. His research also explores the effects of gabapentin and D-cycloserine in individuals maintained on methadone, utilizing novel response discrimination procedures.
His scholarly contributions include 14 publications with a total of 203 citations and an h-index of 7. Guise collaborates with several colleagues at the University of Arkansas for Medical Sciences, including Michael J. Mancino and Alison Oliveto, with whom he has co-authored multiple publications.
Metrics
- h-index: 7
- Publications: 14
- Citations: 207
Selected Publications
-
Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone (2025)
-
Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure (2025)
-
THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN (2024)
Collaboration Network
Top Collaborators
Michael J. Mancino
University of Arkansas for Medical Sciences
3 shared publications
In database
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Alison Oliveto
University of Arkansas for Medical Sciences
3 shared publications
In database
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Azizi Ray
University of Arkansas for Medical Sciences
2 shared publications
In database
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Edward V. Nunes
Columbia University Irving Medical Center (US)
2 shared publications
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Jeff Thostenson
University of Arkansas for Medical Sciences (US)
1 shared publication
- THE IMPACT OF FENTANYL ON TREATMENT OUTCOMES DURING AN OUTPATIENT BUPRENORPHINE TAPER WITH ADJUNCT GABAPENTIN
Lauren R. Fitzgerald
University of Arkansas for Medical Sciences
1 shared publication
In database
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
Nichole Stanley
Arkansas Department of Health (US)
1 shared publication
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
Christopher Cargile
University of Arkansas for Medical Sciences
1 shared publication
In database
- Gabapentin and D-cycloserine alone and in combination with naloxone in methadone-maintained humans responding under a naloxone novel-response discrimination procedure
Jeff D. Thostenson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Howard P. Hendrickson
Samford University (US)
1 shared publication
- Randomized, placebo-controlled trial of gabapentin during outpatient buprenorphine-assisted taper and transition to injectable naltrexone
Similar Researchers
Based on overlapping research topics
Morgan Streett
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Anesthesia and Pain Management
Shona Ray-Griffith
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Behavioral Health and Interventions
Health Sciences Research and Education
Jackson W Weaver
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions
Azizi Ray
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions
Mance E. Buttram
University of Arkansas at Fayetteville
Substance Abuse Treatment and Outcomes
Pharmacological Effects and Toxicity Studies
Behavioral Health and Interventions
Michael Mancino
University of Arkansas for Medical Sciences
Substance Abuse Treatment and Outcomes
Behavioral Health and Interventions
Health Sciences Research and Education